Meropenem Bausch Health

Meropenem, the active ingredient in Meropenem Bausch Health, is a carbapenem presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and septicemia in hospitalized patients.

GNH USA supplies Meropenem Bausch Health as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: achieves bacterial eradication in severe intra‑abdominal infections. Complicated urinary tract infections: clears resistant uropathogens in complicated UTIs. Nosocomial pneumonia: effective against hospital‑acquired lower respiratory infections. Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. Septicemia: rapidly eliminates bloodstream infections caused by susceptible organisms.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Infusion site reactions: erythema or pain at the injection site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile infection: severe colitis risk. - Anaphylaxis: life‑threatening hypersensitivity reaction. - Severe neutropenia: marked reduction in white blood cell count.

Clinicians should consider several safety measures before initiating meropenem. - Renal impairment: adjust dose based on creatinine clearance. - History of seizures: monitor neurologic status closely. - Known hypersensitivity: avoid use in patients allergic to β‑lactams. - Concomitant CNS disorders: use with caution due to seizure risk. - Liver function: monitor enzymes during prolonged therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate levels, risking seizure breakthrough. - Other carbapenems: concurrent use may increase toxicity without added benefit. - High‑dose aminoglycosides: combined nephrotoxic potential. - Loop diuretics: may exacerbate renal dysfunction.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, requiring closer monitoring. - Oral contraceptives: reduced efficacy, advise alternative contraception. - Diuretics: electrolyte disturbances may be amplified. - Other nephrotoxic agents: monitor renal function and adjust dosing as needed.